3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Warts
1
Neutropenia
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Leukopenia
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Infections
1
Immunologic Deficiency Syndromes
1
Hematologic Neoplasms
1
Agammaglobulinemia
1
Acquired Immunodeficiency Syndrome
1
Interventions
fludarabine
6
Cyclophosphamide
5
fludarabine phosphate
4
Melphalan
3
Busulfan
3
trametinib
2
thymoglobulin
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Methotrexate
2
Cytarabine
2
Biopsy
2
omipalisib
1
merphos
1
imetelstat
1
hydrocortisone hemisuccinate
1
blinatumomab
1
Transplantation
1
Thiotepa
1
Spinal Puncture
1
Sirolimus
1
Rituximab
1
Radiotherapy
1
Mesna
1
Levetiracetam
1
Leucovorin
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Juvenile
×
plerixafor
×
90 days
×
Clear all
No trials found.